Loring Wolcott & Coolidge Fiduciary Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5M | Buy |
|
|||||
|
2025
Q1 | $56.7M | Sell |
|
|||||
|
2024
Q4 | $72.6M | Sell |
|
|||||
|
2024
Q3 | $102M | Buy |
|
|||||
|
2024
Q2 | $114M | Buy |
|
|||||
|
2024
Q1 | $78.6M | Buy |
|
|||||
|
2023
Q4 | $57.9M | Buy |
|
|||||
|
2023
Q3 | $36M | Buy |
|
|||||
|
2023
Q2 | $12M | Buy |
|
|||||
|
2023
Q1 | $10.5M | Buy |
|
|||||
|
2022
Q4 | $9.09M | Buy |
|
|||||
|
2022
Q3 | $8.22M | Buy |
|
|||||
|
2022
Q2 | $6.5M | Buy |
|
|||||
|
2022
Q1 | $7.62M | Buy |
|
|||||
|
2021
Q4 | $6.85M | Buy |
|
|||||
|
2021
Q3 | $6.48M | Buy |
|
|||||
|
2021
Q2 | $5.97M | Buy |
|
|||||
|
2021
Q1 | $4.79M | Buy |
|
|||||
|
2020
Q4 | $77K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $119K | Sell |
|
|||||
|
2017
Q4 | $280K | Hold |
|
|||||
|
2017
Q3 | $333K | Buy |
|
|||||
|
2017
Q2 | $120K | Hold |
|
|||||
|
2017
Q1 | $95K | Hold |
|
|||||
|
2016
Q4 | $90K | Hold |
|
|||||
|
2016
Q3 | $98K | Hold |
|
|||||
|
2016
Q2 | $86K | Hold |
|
|||||
|
2016
Q1 | $88K | Hold |
|
|||||
|
2015
Q4 | $133K | Hold |
|
|||||
|
2015
Q3 | $125K | Hold |
|
|||||
|
2015
Q2 | $125K | Buy |
|
|||||
|
2015
Q1 | $84K | Buy |
|
|||||
|
2014
Q4 | $41K | Buy |
|